These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 15198833)
1. Closing the loop: the adicol experience. Hovorka R; Chassin LJ; Wilinska ME; Canonico V; Akwi JA; Federici MO; Massi-Benedetti M; Hutzli I; Zaugg C; Kaufmann H; Both M; Vering T; Schaller HC; Schaupp L; Bodenlenz M; Pieber TR Diabetes Technol Ther; 2004 Jun; 6(3):307-18. PubMed ID: 15198833 [TBL] [Abstract][Full Text] [Related]
2. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes. Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E; Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304 [TBL] [Abstract][Full Text] [Related]
3. Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes. Wilinska ME; Chassin LJ; Acerini CL; Allen JM; Dunger DB; Hovorka R J Diabetes Sci Technol; 2010 Jan; 4(1):132-44. PubMed ID: 20167177 [TBL] [Abstract][Full Text] [Related]
4. Artificial neural networks for closed loop control of in silico and ad hoc type 1 diabetes. Fernandez de Canete J; Gonzalez-Perez S; Ramos-Diaz JC Comput Methods Programs Biomed; 2012 Apr; 106(1):55-66. PubMed ID: 22178070 [TBL] [Abstract][Full Text] [Related]
5. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903 [TBL] [Abstract][Full Text] [Related]
6. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes. Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572 [TBL] [Abstract][Full Text] [Related]
7. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus. Shichiri M; Kawamori R; Hakui N; Asakawa N; Yamasaki Y; Abe H Biomed Biochim Acta; 1984; 43(5):561-8. PubMed ID: 6477542 [TBL] [Abstract][Full Text] [Related]
8. The artificial pancreas: how close are we to closing the loop? Clarke WL; Kovatchev B Pediatr Endocrinol Rev; 2007 Jun; 4(4):314-6. PubMed ID: 17643078 [No Abstract] [Full Text] [Related]
9. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas. Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512 [TBL] [Abstract][Full Text] [Related]
10. [Closed-Loop at night for the treatment of type 1 diabetes]. Danne T; Kordonouri O Dtsch Med Wochenschr; 2014 Oct; 139(42):2156. PubMed ID: 25289927 [TBL] [Abstract][Full Text] [Related]
11. Diabetes technology and treatments in the paediatric age group. Shalitin S; Peter Chase H Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816 [TBL] [Abstract][Full Text] [Related]
12. A gain-scheduling model predictive controller for blood glucose control in type 1 diabetes. Abu-Rmileh A; Garcia-Gabin W IEEE Trans Biomed Eng; 2010 Oct; 57(10):2478-84. PubMed ID: 19846371 [TBL] [Abstract][Full Text] [Related]